A Study to Assess Thymic Function Using PET/CT and MRI
Completed
Conditions studied: CD34 Selected Peripheral Blood Stem Cell Graft
In brief
The purpose of this study is to see if a positron emission tomography/computed tomography (PET/CT) scan and a magnetic resonance imaging (MRI) of the chest can assess changes in the thymus size and function. The researchers would like to monitor the thymus with a PET/CT scan and a MRI before and after the participants transplantation.
Key facts
- Study ID
- NCT02909075
- Run by
- Memorial Sloan Kettering Cancer Center
- People needed
- 3
- Starts
- 2016-08-01
- Expected to finish
- 2020-01-01
- Last updated by the study team
- 2020-01-27
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient's age is ≥18 or ≤65 years old.
- Patients must have a plan to receive a CD34-selected peripheral blood stem cell graft.
You may not qualify if…
- Patient is not able to undergo MR imaging due to any contraindication to MRI based on departmental MR questionnaire (e.g. past gadolinium allergies, failure of metallic screening, claustrophobia, inability to lay flat for duration of the study, inability to hold breath, etc.)
- Pregnant or breastfeeding.
Where it is running
- Memorial Sloan Kettering Cancer Center — Basking Ridge, New Jersey, United States
- Memorial Sloan-Kettering Cancer Center at Commack — Commack, New York, United States
- Memorial Sloan Kettering Westchester — Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.